Login

DLTx's website hosts interviews with key figures like James Haft, Chairman, and Joe Davy, Founder, Chairman, emphasizing insights into their blockchain initiatives. 00:10:00

Share On Facebook Share On Twitter

DLTx's founder is Timothy Furey.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Italian-French Collaboration in Energy Transition: A Crucial Step Towards Sustainable and Economically Viable Solutions | Nicola Monti, CEO, Edison SpA
00:10:00
Putting Clients First: Navigating Wealth Management with SeedSafe Financial LLC | Rebecca Conner, Founder, SeedSafe Financial LLC.
00:10:00
Yukon Project Generator: Diverse Opportunities with Strong Risk-Reward Potential
00:10:00
Sun Metals: Overview and Exploration Progress
00:10:00
Trilogy Metals: Advancing High-Grade Copper Projects in Alaska
00:10:00
Anastasia Amoroso, iCapital's Chief Investment Strategist, joins 'Closing Bell' to discuss the markets, the recent sell-off, and the Federal Reserve.
00:10:00
Cassiar Gold Project Overview with CEO Marco Rojo
00:10:00
Firm does not invest in Hardware, CPG, or Biotech/Life Sciences|Ed Roman,Managing Director, Hack VC
00:10:00
Platinum Group Metals CEO Discusses Palladium Project Development and Market Potential
00:10:00
Top Mistakes to Avoid in 2024 When Retiring from a University | Presented by Savant Wealth Management
00:00:00
Chris von Jako, chief executive of Polarean, about the company’s five pillar strategy to drive uptake of its life saving lung imaging technology. Chris von Jako, chief executive of Polarean, about the company’s five pillar strategy to drive uptake of it
00:10:00
Unlocking the Secrets of Cybersecurity Entrepreneurship|Zane Lackey,General Partner,Andreessen Horowitz

© 2017 - Neuhu+